Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 10-Q

 

ý  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarter Ended September 30, 2003

 

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period From                    to

 


 

Commission File Number 0-10964

 

MAXWELL TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

95-2390133

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

9244 Balboa Avenue, San Diego, CA

 

92123

(Address of principal executive office)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code:  (858) 503-3300

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes         ý            No           o

 

Indicate by check mark whether registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

Yes         ý            No           o

 

As of November 7, 2003, Registrant had only one class of common stock, of which there were 13,815,313 shares outstanding.

 

 



 

MAXWELL TECHNOLOGIES, INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
For the quarter ended September 30, 2003

 

PART I

 

Item 1.

Consolidated Financial Statements

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Item 4.

Controls and Procedures

 

 

PART II

 

Item 1.

Legal Proceedings

Item 2.

Changes in Securities and Use of Proceeds

Item 3.

Defaults Upon Senior Securities

Item 4.

Submission of Matters to a Vote of Security Holders

Item 5.

Other Information

Item 6.

Exhibits and Reports on Form 8-K

 

Unless the context otherwise requires, all references in this Quarterly Report on Form 10-Q to “Maxwell,” the “Company,” “we,” “us,” and “our” refer to Maxwell Technologies, Inc. and its subsidiaries; all references to “Montena Components” refer to our subsidiary Montena Components, Ltd. which has been renamed Maxwell Technologies, SA; all references to “Electronic Components Group” refer to our former subsidiary, Maxwell Electronic Components Group, Inc. which has been merged into Maxwell; all references to “I-Bus/Phoenix” refer to our subsidiary, I-Bus/Phoenix, Inc., and its subsidiaries; and all references to “PurePulse” refer to our subsidiary, PurePulse Technologies, Inc.  This Form 10-Q may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve risks and uncertainties. The Company’s actual results may differ significantly from the results discussed in any forward-looking statements. Factors that might cause such a difference include, but are not limited to those discussed in “Risk Factors” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2002. Discussions containing such forward-looking statements may be found in the material set forth under “Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as within this Form 10-Q generally.

 

2



 

MAXWELL TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)

 

 

 

September 30,
2003

 

December 31,
2002

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

3,086

 

$

3,545

 

Short-term investments

 

2,689

 

7,546

 

Trade and other accounts receivable, net

 

7,893

 

8,530

 

Inventories

 

9,340

 

11,833

 

Prepaid expenses and other current assets

 

1,938

 

1,037

 

Assets held-for-sale

 

7,356

 

7,356

 

Total current assets

 

32,302

 

39,847

 

Property, plant and equipment, net

 

10,598

 

11,653

 

Other intangible assets, net

 

1,981

 

2,009

 

Goodwill

 

18,190

 

17,577

 

Other non-current assets

 

293

 

294

 

 

 

$

63,364

 

$

71,380

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and other accrued liabilities

 

$

6,825

 

$

10,626

 

Accrued warranty

 

1,176

 

882

 

Deferred revenue

 

5,126

 

2,305

 

Accrued employee compensation

 

2,079

 

1,590

 

Short-term borrowings and current portion of long-term debt

 

3,692

 

570

 

Deferred tax liability

 

498

 

272

 

Liabilities of discontinued operations

 

2,161

 

2,326

 

Total current liabilities

 

21,557

 

18,571

 

 

 

 

 

 

 

Deferred tax liability

 

183

 

183

 

Long-term debt, excluding current portion

 

 

2,675

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock, $0.10 par value per share, 40,000 shares authorized; 13,816 and 13,726 shares issued and outstanding at September 30, 2003 and December 31, 2002, respectively

 

1,382

 

1,373

 

Additional paid-in capital

 

108,824

 

112,255

 

Common shares issuable

 

4,098

 

 

Accumulated deficit

 

(73,889

)

(64,015

)

Accumulated other comprehensive income

 

1,209

 

338

 

Total stockholders’ equity

 

41,624

 

49,951

 

 

 

$

63,364

 

$

71,380

 

 

See notes to consolidated financial statements

 

3



 

MAXWELL TECHNOLOGIES, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

10,993

 

$

16,564

 

$

31,887

 

$

42,509

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of sales

 

9,408

 

13,858

 

27,634

 

39,651

 

Selling, general and administrative

 

2,611

 

5,171

 

10,188

 

14,766

 

Research and development

 

1,597

 

2,167

 

4,478

 

7,080

 

Impairment of long lived assets

 

 

7,628

 

 

7,628

 

Loss (gain) on sale of business

 

(263

)

7,219

 

(726

)

7,219

 

Restructuring charge

 

 

922

 

 

1,734

 

Other

 

(23

)

261

 

(18

)

29

 

Total costs and expenses

 

13,330

 

37,226

 

41,556

 

78,107

 

Loss from continuing operations before income taxes

 

(2,337

)

(20,662

)

(9,669

)

(35,598

)

Provision (benefit) for income taxes

 

(149

)

124

 

(249

)

(155

)

Minority interest in net loss of subsidiaries